Literature DB >> 7577992

Binding modes for substrate and a proposed transition-state analogue of protozoan nucleoside hydrolase.

D W Parkin1, V L Schramm.   

Abstract

The transition-state structure for inosine-uridine nucleoside hydrolase (IU-nucleoside hydrolase) from Crithidia fasciculata is characterized by oxycarbonium character in the ribosyl and weak bonds to the departing hypoxanthine and incipient water nucleophile [Horenstein, B. A., Parkin, D. W., Estupiñán, B., & Schramm, V. L. (1991) Biochemistry 30, 10788-10795]. Inhibitors designed to resemble the transition state are slow-onset, tight-binding inhibitors with observed Km/Ki values up to 2 x 10(5) [Schramm, V. L., Horenstein, B. H., & Kline, P. C. (1994) J. Biol. Chem. 269, 18259-18262]. Although slow-onset, tight binding is consistent with transition-state stabilization, more direct evidence can be obtained by comparing the groups which interact with the substrate to provide binding and catalysis with those which interact with the putative transition-state inhibitor. The Km value for inosine binding to IU-nucleoside hydrolase is independent of pH over the range 5.6-10.5. Dependencies of Vmax and Vmax/Km on pH result in pH optima near 8.0. A single group with pK of 9.1 must be protonated for catalytic activity, and protonation of a second group with a pK of 7.1 results in loss of activity. 1-(S)-Phenyl-1,4-dideoxy-1,4-imino-D-ribitol (phenyliminoribitol) binds with an equilibrium Kd of 30 nM and has been proposed to be a transition-state inhibitor. The pH dependence for the competitive inhibition by phenyliminoribitol resembles the Vmax profile with the protonation of a single group, pK 7.5, required for inhibitor binding and the protonation of a subsequent group, pK 6.6, causing loss of binding.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577992     DOI: 10.1021/bi00042a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Femtosecond dynamics coupled to chemical barrier crossing in a Born-Oppenheimer enzyme.

Authors:  Rafael G Silva; Andrew S Murkin; Vern L Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  Structure and inhibition of a quorum sensing target from Streptococcus pneumoniae.

Authors:  Vipender Singh; Wuxian Shi; Steven C Almo; Gary B Evans; Richard H Furneaux; Peter C Tyler; Gavin F Painter; Dirk H Lenz; Simon Mee; Renjian Zheng; Vern L Schramm
Journal:  Biochemistry       Date:  2006-10-31       Impact factor: 3.162

3.  Structural explanation for the tunable substrate specificity of an E. coli nucleoside hydrolase: insights from molecular dynamics simulations.

Authors:  Stefan A P Lenz; Stacey D Wetmore
Journal:  J Comput Aided Mol Des       Date:  2018-11-26       Impact factor: 3.686

4.  Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation.

Authors:  Ana P Guimarães; Aline A Oliveira; Elaine F F da Cunha; Teodorico C Ramalho; Tanos C C França
Journal:  J Mol Model       Date:  2011-02-12       Impact factor: 1.810

5.  Purification, characterization, and gene cloning of purine nucleosidase from Ochrobactrum anthropi.

Authors:  J Ogawa; S Takeda; S X Xie; H Hatanaka; T Ashikari; T Amachi; S Shimizu
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

Review 6.  Glycosidase inhibition: assessing mimicry of the transition state.

Authors:  Tracey M Gloster; Gideon J Davies
Journal:  Org Biomol Chem       Date:  2009-11-05       Impact factor: 3.876

7.  Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics.

Authors:  Keith Clinch; Gary B Evans; Richard F G Fröhlich; Shivali A Gulab; Jemy A Gutierrez; Jennifer M Mason; Vern L Schramm; Peter C Tyler; Anthony D Woolhouse
Journal:  Bioorg Med Chem       Date:  2012-07-14       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.